Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 178422083, 화합물 → HCID 178422098, 화합물
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | HCID 178422083 | HCID 178422083 | — |
| 반응물 | HCID 178453727 | HCID 178453727 | — |
| 생성물 | HCID 178422098 | HCID 178422098 | — |
반응 단계
The title compound was prepared according to the procedure described in the preparation of 2-((2S)-bicyclo[2.2.1]heptan-2-ylamino)-5-methyl-5-(piperidin-4-ylmethyl)thiazol-4(5H)-one by using tert-butyl 2-(3-(4-((2-((2S)-bicyclo[2.2.1]heptan-2-ylamino)-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl)methyl)piperidine-1-carbonyl)phenoxy)ethylcarbamate (689 mg, 1.18 mmol) as the starting material. The title compound was obtained as an off-white solid (531 mg). MS (ESI, pos. ion) m/z: 485 (M+H)
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07253196B2 |
| 출처 데이터셋 | uspto-grants-2007_08 |
| ORD ID | ord-28b645aa219c432cb01d05eca3a5eade |
| 출처 메모 | uspto-grants-2007_08 |